Laurel Wealth Advisors, Inc. Eli Lilly & CO Transaction History

Laurel Wealth Advisors, Inc.

$1.01 Billion
Q4 2022

A detailed history of Laurel Wealth Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 5,745 shares of LLY stock, worth $4.29 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

5,745

Previous 5,596 2.66%

Holding current value

$4.29 Million

Previous $1.81 Million 16.2%

% of portfolio

0.21%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $47,910 - $55,825	149 Added 2.66%	5,745 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $151,501 - $172,651	511 Added 10.05%	5,596 $1.81 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $119,296 - $140,071	-428 Reduced 7.76%	5,085 $1.65 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $173,201 - $215,245	-738 Reduced 11.81%	5,513 $1.58 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $266,672 - $330,941	1,186 Added 23.42%	6,251 $1.73 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $176,393 - $217,077	-796 Reduced 13.58%	5,065 $1.17 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $4,694 - $6,072	-26 Reduced 0.44%	5,861 $1.35 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $111,080 - $143,798	676 Added 12.97%	5,887 $1.1 Million
Q4 2020 Mar 03, 2021	SELL	$130.46 - $172.63 $10,306 - $13,637	-79 Reduced 1.49%	5,211 $880,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $25,734 - $29,766	-176 Reduced 3.22%	5,290 $783,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $6,275 - $7,552	46 Added 0.85%	5,466 $898,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $7,738 - $9,577	-65 Reduced 1.19%	5,420 $752,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $623,022 - $771,669	-5,827 Reduced 51.51%	5,485 $721,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $638,817 - $694,869	5,982 Added 112.23%	11,312 $1.27 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $15,953 - $18,622	144 Added 2.78%	5,330 $590,000
Q1 2019 May 16, 2019	SELL	$111.31 - $131.02 $29,497 - $34,720	-265 Reduced 4.86%	5,186 $673,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $2,223 - $2,491	-21 Reduced 0.38%	5,451 $630,000
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $2,232 - $2,790	26 Added 0.48%	5,472 $587,000
Q2 2018 Aug 20, 2018	SELL	$75.7 - $86.88 $4,239 - $4,865	-56 Reduced 1.02%	5,446 $464,000
Q1 2018 May 16, 2018	SELL	$74.21 - $87.6 $21,298 - $25,141	-287 Reduced 4.96%	5,502 $425,000
Q4 2017 Feb 15, 2018	BUY	$81.94 - $87.89 $68,256 - $73,212	833 Added 16.81%	5,789 $488,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $154 - $171	2 Added 0.04%	4,956 $423,000
Q2 2017 Aug 15, 2017	BUY	N/A	4,954	4,954 $407,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.

Account

Laurel Wealth Advisors, Inc. Eli Lilly & CO Transaction History